1. Home
  2. AVDL vs ADSE Comparison

AVDL vs ADSE Comparison

Compare AVDL & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • ADSE
  • Stock Information
  • Founded
  • AVDL 2015
  • ADSE 1980
  • Country
  • AVDL Ireland
  • ADSE Ireland
  • Employees
  • AVDL N/A
  • ADSE N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • ADSE Industrial Specialties
  • Sector
  • AVDL Health Care
  • ADSE Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • ADSE Nasdaq
  • Market Cap
  • AVDL 764.3M
  • ADSE 807.1M
  • IPO Year
  • AVDL 1996
  • ADSE N/A
  • Fundamental
  • Price
  • AVDL $7.91
  • ADSE $15.00
  • Analyst Decision
  • AVDL Strong Buy
  • ADSE Hold
  • Analyst Count
  • AVDL 7
  • ADSE 1
  • Target Price
  • AVDL $18.86
  • ADSE $14.00
  • AVG Volume (30 Days)
  • AVDL 1.5M
  • ADSE 140.6K
  • Earning Date
  • AVDL 03-03-2025
  • ADSE 04-29-2025
  • Dividend Yield
  • AVDL N/A
  • ADSE N/A
  • EPS Growth
  • AVDL N/A
  • ADSE N/A
  • EPS
  • AVDL N/A
  • ADSE N/A
  • Revenue
  • AVDL $169,117,000.00
  • ADSE $158,974,606.00
  • Revenue This Year
  • AVDL $51.49
  • ADSE $101.72
  • Revenue Next Year
  • AVDL $32.18
  • ADSE $55.77
  • P/E Ratio
  • AVDL N/A
  • ADSE N/A
  • Revenue Growth
  • AVDL 504.79
  • ADSE 168.42
  • 52 Week Low
  • AVDL $7.39
  • ADSE $9.52
  • 52 Week High
  • AVDL $19.09
  • ADSE $16.35
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 43.28
  • ADSE 52.58
  • Support Level
  • AVDL $7.45
  • ADSE $13.80
  • Resistance Level
  • AVDL $7.97
  • ADSE $15.07
  • Average True Range (ATR)
  • AVDL 0.37
  • ADSE 0.67
  • MACD
  • AVDL -0.01
  • ADSE -0.01
  • Stochastic Oscillator
  • AVDL 33.82
  • ADSE 88.28

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About ADSE ADS-TEC ENERGY PLC

ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.

Share on Social Networks: